Emergent BioSolutions Inc. Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Sep 2026Filed 03/11/2026 | Jun 2026Filed 03/11/2026 | Mar 2026Filed 03/11/2026 | Sep 2025Filed 03/11/2026 | Jun 2025Filed 03/11/2026 | Mar 2025Filed 03/11/2026 | Sep 2024Filed 30/10/2025 | Jun 2024Filed 30/10/2025 |
|---|---|---|---|---|---|---|---|---|
| $110 | $234 | $156 | $231 | $141 | $222 | $294 | $255 | |
| −$33 | −$180 | $6.8 | $51 | −$12 | $68 | $115 | −$283 | |
| −$0.64 | −$3.49 | $0.07 | $0.91 | −$0.22 | $1.19 | $2.06 | −$5.38 | |
| 51 | 52 | 57 | 57 | 54 | 57 | 56 | 53 |
Trend